Business Wire

SPPI INVESTORS HAVE OPPORTUNITY TO LEAD SPECTRUM PHARMACEUTICALS, INC. SECURITIES FRAUD LAWSUIT WITH THE SCHALL LAW FIRM

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Spectrum Pharmaceuticals, Inc. (“Spectrum” or “the Company”) (NASDAQ: SPPI) for ...
Nasdaq

Spectrum (SPPI) Down as FDA Panel Votes Against NSCLC Drug

Shares of Spectrum Pharmaceuticals, Inc. SPPI were down 32.6% on Friday after the company announced that the FDA's Oncologic Drugs Advisory Committee (“ODAC”) did not vote in favor of its pipeline ...
Nasdaq

Spectrum's (SPPI) NSCLC Drug Gets FDA's Fast Track Designation

Spectrum Pharmaceuticals, Inc. SPPI announced that the FDA has granted a Fast Track designation to its pipeline candidate, poziotinib, which is being developed for the treatment of non-small cell lung ...
AOL

Here’s What Hedge Funds Think About Spectrum Pharmaceuticals, Inc. (SPPI)

Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our ...
Business Insider

Spectrum Class Action: Levi & Korsinsky Reminds Spectrum Pharmaceuticals, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 3, 2023 ...

New York, New York--(Newsfile Corp. - January 19, 2023) - Levi & Korsinsky, LLP notifies investors in Spectrum Pharmaceuticals, Inc. ("Spectrum" or the "Company") (NASDAQ: SPPI) of a class action ...